NUVO vs. CVRX, RCEL, DCTH, PROF, NPCE, ARAY, DRTS, TLSI, CLPT, and QIPT
Should you be buying Holdco Nuvo Group D.G stock or one of its competitors? The main competitors of Holdco Nuvo Group D.G include CVRx (CVRX), AVITA Medical (RCEL), Delcath Systems (DCTH), Profound Medical (PROF), NeuroPace (NPCE), Accuray (ARAY), Alpha Tau Medical (DRTS), TriSalus Life Sciences (TLSI), ClearPoint Neuro (CLPT), and Quipt Home Medical (QIPT). These companies are all part of the "surgical & medical instruments" industry.
CVRx (NASDAQ:CVRX) and Holdco Nuvo Group D.G (NASDAQ:NUVO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, community ranking, institutional ownership, analyst recommendations and media sentiment.
In the previous week, CVRx had 1 more articles in the media than Holdco Nuvo Group D.G. MarketBeat recorded 2 mentions for CVRx and 1 mentions for Holdco Nuvo Group D.G. CVRx's average media sentiment score of 1.87 beat Holdco Nuvo Group D.G's score of 0.44 indicating that Holdco Nuvo Group D.G is being referred to more favorably in the news media.
CVRx presently has a consensus target price of $16.60, suggesting a potential upside of 62.75%. Given Holdco Nuvo Group D.G's higher possible upside, analysts clearly believe CVRx is more favorable than Holdco Nuvo Group D.G.
75.3% of CVRx shares are owned by institutional investors. 18.9% of CVRx shares are owned by company insiders. Comparatively, 24.2% of Holdco Nuvo Group D.G shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Holdco Nuvo Group D.G has lower revenue, but higher earnings than CVRx.
CVRx received 16 more outperform votes than Holdco Nuvo Group D.G when rated by MarketBeat users.
Holdco Nuvo Group D.G has a net margin of 0.00% compared to Holdco Nuvo Group D.G's net margin of -123.58%. CVRx's return on equity of 0.00% beat Holdco Nuvo Group D.G's return on equity.
CVRx has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500. Comparatively, Holdco Nuvo Group D.G has a beta of -0.25, indicating that its share price is 125% less volatile than the S&P 500.
Summary
CVRx and Holdco Nuvo Group D.G tied by winning 7 of the 14 factors compared between the two stocks.
Get Holdco Nuvo Group D.G News Delivered to You Automatically
Sign up to receive the latest news and ratings for NUVO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NUVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Holdco Nuvo Group D.G Competitors List
Related Companies and Tools
